The primary goal of this study is to document long-term safety outcomes in somatotropin-deficient adults who are given somatotropin replacement therapy as compared with similar patients who elect not to be treated with the same. The secondary goals are: 1) establish specific algorithms for safe and effective somatotropin dosage in adults, and 2) to evaluate the effect of somatropin replacement therapy in conjunction with other hormonal therapies.
Showing the most recent 10 out of 675 publications